Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden
- 23 March 2004
- journal article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 9 (6) , 547-549
- https://doi.org/10.1038/sj.mp.4001504
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent PatientsNeuropsychopharmacology, 2003
- Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Pharmacotherapy of addictionsNature Reviews Drug Discovery, 2002
- The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor BlockadeNeuropsychopharmacology, 2002
- Opioid receptor and peptide gene polymorphisms: potential implications for addictionsEuropean Journal of Pharmacology, 2000
- Morphine self-administration in µ-opioid receptor-deficient miceNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2000
- Co-occurrence of Abuse of Different Drugs in MenArchives of General Psychiatry, 1998
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addictionProceedings of the National Academy of Sciences, 1998
- Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor geneNature, 1996
- Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred MiceaAnnals of the New York Academy of Sciences, 1992